Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

FAM160B1 Inhibitors

FAM160B1 inhibitors encompass a specific category of chemical compounds designed to attenuate or suppress the activity of the FAM160B1 protein. These inhibitors function through diverse mechanisms to interfere with the pathways that FAM160B1 is involved in, ultimately reducing its activity within the cell. The chemical makeup of these inhibitors is varied, but they share the common goal of targeting the biological processes that FAM160B1 influences. By inhibiting FAM160B1, these compounds could potentially alter signaling pathways, transcriptional regulation, protein-protein interactions, or other cellular processes that the FAM160B1 protein normally participates in. The specificity of these inhibitors is crucial, as they aim to selectively inhibit FAM160B1 without affecting a wide array of other proteins, which helps to reduce off-target effects and increases the specificity of the inhibition.

The modes of action of FAM160B1 inhibitors are manifold: some may bind directly to the FAM160B1 protein, interfering with its ability to interact with other molecules or substrates necessary for its function. Others might inhibit the protein indirectly by modulating upstream or downstream factors within the signaling pathways that FAM160B1 is known to be a part of. These inhibitors could affect the phosphorylation state, conformation, or localization of FAM160B1, leading to a decreased functional capacity of the protein. Through such targeted actions, FAM160B1 inhibitors exert their effects at the molecular level, disrupting the normal homeostatic roles of FAM160B1 and thus providing a means of controlling processes in which FAM160B1 is deemed to play a pivotal role. The development and specificity of these inhibitors are grounded in a comprehensive understanding of the structural and functional nuances of the FAM160B1 protein, ensuring that they achieve the desired inhibitory effect with minimal unintended consequences.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

Staurosporine is a potent inhibitor of protein kinases. By inhibiting these kinases, it can indirectly lead to the deactivation of FAM160B1 if the protein relies on phosphorylation for its activity.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin binds to FKBP12 and the complex inhibits mTOR, which is a central regulator of cell growth and proliferation. Inhibition of mTOR signaling may decrease the functional activity of FAM160B1 if it is involved in these cellular processes.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor. By blocking PI3K, it suppresses the AKT signaling pathway, which could result in reduced activity of FAM160B1 if it is downstream of this pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

PD98059 is a MEK inhibitor, which prevents the activation of the ERK pathway, potentially leading to decreased activation of FAM160B1 if it is regulated by this pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is a p38 MAPK inhibitor. Inhibiting p38 MAPK can reduce the activity of FAM160B1 if it is part of the p38 MAPK-regulated signaling events.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK). If FAM160B1 activity is associated with JNK signaling, its inhibition may lead to reduced FAM160B1 function.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a PI3K inhibitor similar to LY294002. It could lead to decreased FAM160B1 activity by inhibiting signaling pathways that rely on PI3K activity.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

U0126 is an inhibitor of MEK, which also impairs the ERK pathway. This may lead to decreased activity of FAM160B1 if FAM160B1 function is modulated by the ERK signaling.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Bortezomib is a proteasome inhibitor. By preventing protein degradation, it may indirectly affect the levels and activity of FAM160B1 if its regulation involves proteasomal degradation.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$56.00
$260.00
$980.00
163
(3)

MG132 is another proteasome inhibitor that could lead to the accumulation or decreased turnover of FAM160B1, affecting its functional activity.